Halcinonide
As of the edition of 20 October 2026, Halcinonide is a small molecule: marketed, first approved in 1982 (US); acts on NR3C1; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1982
- Kind
- Small molecule
- Brand name
- Halog
- First approved
- 1 January 1982 (US)
- Approvals on record
- 6 in 1 region
- Holder of the most recent approval
- SUN Pharmaceutical Industries; 3 holders in all
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| NR3C1 | Glucocorticoid receptor | P04150 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| SUN Pharmaceutical Industries | Acquired holder | 2018 to now |
| Bristol Myers Squibb | Later holder | |
| Westwood Squibb Pharmaceuticals | Later holder |